Based on this signaling pathway, we identified significant changes in TNF-α, IL-6, and matrix metallopeptidase 10 (MMP-10) gene expression when we performed RT-PCR in PC3 and 22RV1 prostate cancer cells, thus, we wanted to determine if there would be significant changes in expression in an in vivo mouse model. This evidence concerns the gene MMP10 and prostate cancer.